Gene · 80310
NIH grants1,097
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 1,097
Download this page as JSON| Grant | Title | PDGFD papers | Newest fiscal year |
|---|---|---|---|
| R01CA116021 | New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors | 1 | 2024 |
| R01CA154475 | NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA | 1 | 2024 |
| R01CA231349 | Developing Novel Therapeutic Approaches Targeting Macrophages in GBM | 1 | 2024 |
| R01CA236781 | Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi | 1 | 2024 |
| R01CA247550 | Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells | 1 | 2024 |
| R01DK057539 | Role of Forkhead proteins in insulin action | 1 | 2024 |
| R01DK128289 | Hepatic stellate cells in NASH fibrosis and HCC | 1 | 2024 |
| R01DK130340 | Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammation | 1 | 2024 |
| R01EB015611 | Solar-Eclipse Computational Tools for Imaging Genetics | 1 | 2024 |
| R01ES031253 | Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | 1 | 2024 |
| R01HL035464 | Dietary Etiologies of Heart Disease | 1 | 2024 |
| R01HL059367 | Epidemiology of Venous Thrombosis and Pulmonary Embolism | 1 | 2024 |
| R01HL106089 | Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells | 1 | 2024 |
| R01HL133951 | Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension | 1 | 2024 |
| R01HL151535 | Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway. | 1 | 2024 |
| R01HL156362 | The role of signaling adaptor protein epsin in atherosclerosis | 1 | 2024 |
| R01HL158097 | Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease | 1 | 2024 |
| R01NS117104 | Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma | 1 | 2024 |
| R01NS118039 | Targeting IDH mutations to improve seizure control in glioma patients | 1 | 2024 |
| R25MD007607 | Hispanic Clinical and Translational Research Education and Career Development Program | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/grants?page=12